ALVOW | Alvotech Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.10 - 3.49
52 Week Range	3.10 - 3.49
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	5,864
Average Volume	N/A
Shares Outstanding	1,196,355,547
Market Cap	4,067,608,860
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2022-06-16

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	999
Country	Iceland
Website	ALVOW

Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.

ALVOW's peers: LNTH, TCBPW, BTMDW, GROV-WT, ADALW, NNAVW, EUDAW

*Chart delayed

Analyzing fundamentals for ALVOW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see ALVOW Fundamentals page.

Watching at ALVOW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ALVOW Technicals page.